Investigating the Role of Insurance in Managing the Risks of Gene Editing Technologies

Thesis Overview

<p> The emergence of gene editing technologies, such as CRISPR-Cas9, presents unprecedented opportunities for advancing healthcare, agriculture, and biotechnology. However, these technologies also pose unique risks and ethical considerations, including potential unintended consequences, regulatory challenges, and liability issues. Insurance can play a crucial role in managing these risks by providing financial protection, fostering responsible innovation, and addressing liability concerns. This project seeks to comprehensively investigate the role of insurance in managing the risks of gene editing technologies and provide insights into the development of effective insurance mechanisms to support responsible gene editing practices. <br></p><p> </p><div><div><div><div><div>This project aims to provide valuable insights for insurers, researchers, policymakers, and stakeholders in gene editing technologies on the role of insurance in managing associated risks. By addressing the ethical considerations and social implications of insuring gene editing technologies, this study aims to facilitate the responsible and sustainable development of gene editing practices. Through a comprehensive analysis of insurance frameworks, gene editing risks, and the role of insurance in managing these risks, this project will contribute to the advancement of responsible gene editing and insurance practices.</div></div><div><div><div><div><div></div></div><div><div></div></div></div><div><div><div></div></div><div><div></div></div><div><div></div></div></div></div></div></div></div></div><div><div><br> </div></div><br><p></p>